A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MI / multiple injections

[Related PubMed/MEDLINE]
Total Number of Papers: 11
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MI  (>> Co-occurring Abbreviation)
Long Form:   multiple injections
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2013 5-HT1A sex based differences in Bmax, in vivo KD, and BPND in the nonhuman primate. AM, BPND, CB, dACC, HP, RN
2012 Measurement of 5-HT(1A) receptor density and in-vivo binding parameters of [(18)F]mefway in the nonhuman primate. PET, RN
1999 Frequency and classification of cerebral infarctions in nursing homes over a 17-year period in Shimane prefecture, Japan. CI, HT, LI, VD
1997 Schistosoma mansoni: development and modulation of the granuloma after or multiple exposures in the baboon (Papio cynocephalus anubis). p.i, SI
1992 [Contributing factors to intellectual impairment in patients with multiple lacunar infarctions]. ADL, HDS, MID, PVL
1990 Continuous subcutaneous insulin infusion (CSII), multiple injections (MI) and conventional insulin therapy (CT) in self-selecting insulin-dependent diabetic patients. A comparison of metabolic control, acute complications and patient preferences. CSII, CT, IDDs
1990 White matter lucencies in multi-infarct dementia: a somatosensory evoked potentials and CT study. CCT, CT, MID, WMLA
1988 Effects of intensified insulin treatment on retinal vessels in diabetic patients. CIT, CSII
1987 Effects of continuous subcutaneous insulin infusion versus multiple injections on insulin receptors in insulin-dependent diabetics. CSII, IDDM
10  1986 Plasma somatostatin and plasma glucagon in long-term IDDM without residual B-cell function. No effect of different long-term metabolic control. CTh
11  1984 Continuous subcutaneous insulin infusion (Mill-Hill Infuser) versus multiple injections (Medi-Jector) in the treatment of insulin-dependent diabetes mellitus and the effect of metabolic control on microangiopathy. CSII, IDDM